⭐ #8 A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma 👨⚕️👩⚕️ Zhang Y, Li J et al 👉 https://t.co/E2sGT7Ceyc #NHLsm #CellTherapy #clinicaltrials
6,543 followers
2,454 followers
A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma #lymphoma #lymsm https://t.co/zNmx3F0ROo
4,256 followers
A Prospective of Bi CD19/22 CART in Pts e rr NHL https://t.co/LFcXD2Tn1q ORR 79.3%, CR 34.5%. 12 m PFS 40.0% OS 63.3% 3 m CR: PFS 66.7% & OS 100% at 12 m grade =>3: CRS 28% NT 12.5% #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTce
6,543 followers
New research: A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma: Background The use of T cells expressing chimeric antigen receptor (CAR T) engineered to… https://t.co/U